Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Penn Researchers Get $8M to Study Effects of PDT on Lung Cancer

Facebook Twitter LinkedIn Email Comments
PHILADELPHIA, July 10, 2014 — An $8 million grant from the National Cancer Institute will fund a four-year study of the effects of photodynamic therapy (PDT) on a rare lung cancer associated with asbestos.

The study, involving 102 patients diagnosed with malignant pleural mesothelioma, will be carried out by researchers at the Perelman School of Medicine at the University of Pennsylvania and the Roswell Park Cancer Institute.

All the patients will undergo pleurectomy, a surgery that removes the lung’s lining along with tumors contained within. Half the patients will receive PDT during therapy along with post-operative chemotherapy; half will receive only post-operative chemotherapy.

Patients will be dosed with photofrin, a photosensitizing agent that makes cancer cells more likely to die from light therapy. Photofrin absorbs the laser light and produces an active form of oxygen that can destroy cancer cells left behind after surgery.

The study also will examine the process by which PDT works to destroy tumor cells, as well as the tumors’ vasculature, to look for potential effect-boosting drugs or therapies. Furthermore, the researchers will examine whether certain pathways affect inflammation or cell growth that contribute to treatment failure.

For more information, visit
Jul 2014
AmericasasbestosBiophotonicsBusinesscancerlung cancerNational Cancer InstitutePDTPennsylvaniaPerelman School of MedicinePhiladelphiaphotodynamic therapyPhotofrinResearch & TechnologyRoswell Park Cancer InstituteUniversity of Pennsylvaniamalignant pleural mesotheliomapleurectomylasers

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.